The Latest Breaking News from Sinovac

China finally approves an mRNA COVID vaccine—but only for some foreigners

Beijing's uneasy relationship with mRNA vaccines is all the more relevant as it begins to relax COVID restrictions.

Fortune · Dec 12, 2022

Covid antibodies offer weak defence against fast-spreading BA.5 sub-variant

Antibodies are less effective in protecting people from the stronger, now-dominant BA.5 sub-variant of Covid-19, according to the Department of Medical Sciences.

Bangkok Post · Jul 25, 2022

CanSino's Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?

Key Takeaways: CanSino’s Covid-19 vaccine Convidecia will be admitted to the global Covax program following its approval by the WHO The approval could have limited benefits for the company as the pandemic fades and other products are widely available By Jony Ho

Benzinga · May 26, 2022

COVID: China is developing its own mRNA vaccine – and it's showing early promise

China, the country that first detected the novel coronavirus, remains one of the few not to have imported one of the exceptionally effective mRNA COVID vaccines developed by Pfizer and Moderna. Instead, it has so far relied on vaccines developed by two Chinese companies, Sinovac and Sinopharm. However, this may…

The Conversation · Feb 15, 2022

Can Sinovac protect Indonesia from the Omicron wave?

Most of the vaccinated in the archipelago have been given the Sinovac shot.

Al Jazeera · Feb 7, 2022

Sinovac for ages 3-17 gets ministry nod

A Public Health Ministry sub-committee on immunity promotion has approved the use of Sinovac's Covid-19 vaccine on minors over the age of three, it was announced on Monday.

Bangkok Post · Jan 31, 2022

Sinovac applies to register vaccine for 3-year-olds

Sinovac, the manufacturer of CoronaVac Vaccine, has applied for registration of its vaccine for use with children aged three years and over, Public Health Minister Anutin Charnvirakul said on Monday.

Bangkok Post · Jan 31, 2022

Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows

A third booster dose of a COVID-19 vaccine from either AstraZeneca Plc (NASDAQ: AZN), Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ:

Benzinga · Jan 24, 2022

Omicron in China: New variant weakens Xi Jinping's Covid policies

BEIJING: More than two years into the pandemic most countries are striving to live alongside Covid, accepting the virus as part of everyday life. China, where the pathogen first emerged, exists in an alternate reality, wedded to a zero-tolerance strategy that’s growing harder to maintain.

The Times of India · Jan 19, 2022